https://sites.temple.edu/ticlj/2025/05/01/volume-39-number-1-fall-2024/
The following articles were written and published by student editors of Temple’s International and Comparative Law Journal (TICLJ) as part of Volume 39 during the 2024–2025 academic year. Each piec…
https://noncredit.temple.edu/upload/PhiladelphiaTULearning_Center_Brochure.pdf
Part of the Temple University Health System Corporate Ofice, The Learning Center is located within the historic Budd Company Complex, which had been home to one of Philadelphia’s largest manufacturers. It was here that the Budd Company built the first all-steel automobile body and the first stainless-steel passenger railroad car.
https://pharmacy.temple.edu/sites/pharmacy/files/media/document/TUSP%202024%20GRAD%20PROGRAM%205.9.pdf
The School houses the Moulder Center for Drug Discovery research, The Jayne Haines Center for Pharmacogenomics and Drug Safety, a tissue culture facility for cell-based research, a Proteomics Facility an Addiction Research Lab and a CGMP facility, one of only six based at universities nationwide.
https://sites.temple.edu/trail/files/2021/11/XieXinDamesIROS2021.pdf
Zhanteng Xie, Pujie Xin, and Philip Dames Abstract—This paper proposes a novel neural network-based control policy to enable a mobile robot to navigate safety through environments filled with both static obstacles, such as tables and chairs, and dense crowds of pedestrians. The network architecture uses early fusion to combine a short history of lidar data with kinematic data about nearby ...
https://owlsports.com/news/2025/4/17/mens-tennis-falls-to-charlotte-in-aac-championship-first-round
MEMPHIS, TN. - Men's tennis closed its American Athletic Conference Championship run with a 4-1 loss to Charlotte on Thursday morning in Memphis.
https://www.templehealth.org/about/news/novel-gene-editing-strategy-leverages-unusual-genetic-alteration-to-block-hiv-spread-in-cells
Genetic alterations that give rise to a rare, fatal disorder known as MOGS-CDG paradoxically also protect cells against infection by viruses. Now, Temple scientists have harnessed this unusual protective ability in a novel gene-editing strategy aimed at eliminating HIV-1 infection.